Literature DB >> 26286835

MDR1 polymorphisms have an impact on the prognosis of Chinese diffuse large B cell lymphoma patients.

Ying Ni1,2, Guangli Yin1,2, Zhengrui Xiao1,2, Lei Fan1,2, Li Wang1,2, Yujie Wu1,2, Hanxin Wu1,2, Sixuan Qian1,2, Wei Xu1,2, Jianyong Li1,2, Kourong Miao3,4, Hairong Qiu5,6.   

Abstract

MDR1 (multidrug resistance 1) encodes an adenosine triphosphate (ATP)-dependent efflux transporter that plays a fundamental role in transportation of harmful compounds outside cells to maintain optimal health. The present study was aimed to investigate whether the MDR1 gene single nucleotide polymorphisms (SNPs) were associated with the prognosis of diffuse large B cell lymphoma (DLBCL). Three common SNPs, including C1236T, G2677T/A, and C3435T were focused on, and a total of 150 DLBCL patients from Jiangsu Han population were successively genotyped by polymerase chain reaction-allele-specific primers (PCR-ASP) method or DNA direct sequencing. At locus C1236T, patients carrying T allele (genotype CT and TT) had a prolonged overall survival (OS) when compared with patients with CC genotype (2-year OS 82.6 vs. 60.0 %, respectively; hazard ratio (HR) = 0.1, 95 % confidence interval (CI) 0.01-0.6, p = 0.016). At locus C3435T, complete remission/ complete remission unconfirmed (CR/CRu) rate in C allele group was significantly higher than T allele group (66.7 vs. 51.9 %, respectively; p = 0.009). The progression-free survival (PFS) curves of with T (genotype CT and TT) and without T (genotype CC) were significantly different (2-year PFS 46.4 % in with T group vs. 73.7 % in without T group, respectively; HR = 1.9, 95 % CI 1.0-3.6, p = 0.045). At locus G2677T/A, the age for genotypes AG and AT groups was significantly younger than the other genotypes (51.1 ± 12.6 vs. 57.7 ± 13.4 years, respectively; p = 0.033). In the haplotype analysis of loci 1236-3435, compared with T-C group, the C-T group displayed an inferior PFS rate (2-year PFS 23.0 vs. 50.6 %, respectively; HR = 7.8, 95 % CI 1.9-32.6, p = 0.005), while C-C and T-T groups showed an intermediate PFS rate. Our findings demonstrate that genotype CT + TT at locus C1236T, allele C, and genotype CC at locus C3435T might contribute to a relatively superior prognosis in DLBCL, as well as haplotype of T-C in loci 1236-3435. Besides, genotypes at locus G2677T/A might affect age at diagnosis, which has important prognostic value for DLBCL.

Entities:  

Keywords:  Diffuse large B cell lymphoma (DLBCL); Multidrug resistance 1 (MDR1); Polymorphism; Prognosis

Mesh:

Substances:

Year:  2015        PMID: 26286835     DOI: 10.1007/s13277-015-3930-0

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  32 in total

1.  Single nucleotide polymorphisms in MDR1 gen correlates with outcome in advanced non-small-cell lung cancer patients treated with cisplatin plus vinorelbine.

Authors:  N Viñolas; M Provencio; N Reguart; F Cardenal; V Alberola; J M Sánchez-Torres; F J Barón; M Cobo; I Maestu; I Moreno; C Mesía; A Izquierdo; E Felip; M López-Brea; A Márquez; M Sánchez-Ronco; M Tarón; M C Santarpia; R Rosell
Journal:  Lung Cancer       Date:  2011-02       Impact factor: 5.705

2.  The single nucleotide polymorphism and haplotype analysis of MDR1 in Jiangsu Han population of China.

Authors:  Hairong Qiu; Huajie Dong; Shiyang Pan; Kourong Miao
Journal:  Biomed Pharmacother       Date:  2012-04-03       Impact factor: 6.529

3.  Introduction of combined CHOP plus rituximab therapy dramatically improved outcome of diffuse large B-cell lymphoma in British Columbia.

Authors:  Laurie H Sehn; Jane Donaldson; Mukesh Chhanabhai; Catherine Fitzgerald; Karamjit Gill; Richard Klasa; Nicol MacPherson; Susan O'Reilly; John J Spinelli; Judy Sutherland; Kenneth S Wilson; Randy D Gascoyne; Joseph M Connors
Journal:  J Clin Oncol       Date:  2005-06-13       Impact factor: 44.544

4.  Multidrug resistance gene 1 C1236T polymorphism and susceptibility to leukemia: A meta-analysis.

Authors:  Limin Ma; Hongchao Liu; Linhai Ruan; Xuewen Yang; Haiping Yang; Yanming Feng
Journal:  Biomed Rep       Date:  2014-11-14

5.  Polymorphisms in the human organic cation transporter and the multidrug resistance gene: correlation with imatinib levels and clinical course in patients with chronic myeloid leukemia.

Authors:  Jacob Vine; Sara Bar Cohen; Rosa Ruchlemer; Neta Goldschmidt; Moshe Levin; Diana Libster; Alexander Gural; Moshe E Gatt; David Lavie; Dina Ben-Yehuda; Deborah Rund
Journal:  Leuk Lymphoma       Date:  2014-03-19

6.  Influence of MDR1 C1236T polymorphism on lopinavir plasma concentration and virological response in HIV-1-infected children.

Authors:  Carolina P Bellusci; Carlos Rocco; Paula Aulicino; Debora Mecikovsky; Verónica Curras; Soledad Hegoburu; Guillermo F Bramuglia; Rosa Bologna; Luisa Sen; Andrea Mangano
Journal:  Gene       Date:  2013-03-23       Impact factor: 3.688

7.  Influence of the MDR1 haplotype and CYP3A5 genotypes on cyclosporine blood level in Chinese renal transplant recipients.

Authors:  B Chen; W Zhang; J Fang; Z Jin; J Li; Z Yu; W Cai
Journal:  Xenobiotica       Date:  2009-12       Impact factor: 1.908

Review 8.  The clinical impact of pharmacogenetics on the treatment of epilepsy.

Authors:  Wolfgang Löscher; Ulrich Klotz; Fritz Zimprich; Dieter Schmidt
Journal:  Epilepsia       Date:  2008-07-08       Impact factor: 5.864

9.  A cluster of three single nucleotide polymorphisms in the 3'-untranslated region of human glycoprotein PC-1 gene stabilizes PC-1 mRNA and is associated with increased PC-1 protein content and insulin resistance-related abnormalities.

Authors:  L Frittitta; T Ercolino; M Bozzali; A Argiolas; S Graci; M G Santagati; D Spampinato; R Di Paola; C Cisternino; V Tassi; R Vigneri; A Pizzuti; V Trischitta
Journal:  Diabetes       Date:  2001-08       Impact factor: 9.461

10.  Multi-drug resistance 1 genetic polymorphism and prediction of chemotherapy response in Hodgkin's Lymphoma.

Authors:  Nizar M Mhaidat; Osama Y Alshogran; Omar F Khabour; Karem H Alzoubi; Ismail I Matalka; William J Haddadin; Ibraheem O Mahasneh; Ahmad N Aldaher
Journal:  J Exp Clin Cancer Res       Date:  2011-07-16
View more
  2 in total

1.  Association of MDR1 single-nucleotide polymorphisms and haplotype variants with multiple myeloma in Chinese Jiangsu Han population.

Authors:  Guangli Yin; Zhengrui Xiao; Ying Ni; Xiaoyan Qu; Hanxin Wu; Hua Lu; Sixuan Qian; Lijuan Chen; Jianyong Li; Hairong Qiu; Kourong Miao
Journal:  Tumour Biol       Date:  2016-01-20

2.  Clinical relevance of multi-drug resistance gene C3435T polymorphism in diffuse large B-cell lymphoma in Xinjiang.

Authors:  Wei Liu; Yan Li; Zhenhui Zhao; Xun Li
Journal:  Medicine (Baltimore)       Date:  2020-08-28       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.